Press release
Recurrent Glioblastoma Multiforme (GBM) Treatment Market is Growing at Significant Rate, 2022
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/10112
Alcohol consumption and malaria are the possible risk factors for the development of GBM. In addition, neurofibromatosis, tuberous sclerosis, von-hippel-lindau disease, Li-fraumeni syndrome and turcot syndrome are some of the genetic disorders that are associated with increasing incidences of gliomas. Glioblastoma multiforme is a World Health Organization Grade IV tumor that represents 15 to 20% of all primary intracranial tumors.
Increasing habits of alcohol consumption, changing lifestyle and increasing incidence of seizure are some of the drivers for the growth of GBM market. GBM is generally treated by first surgically removing the tumor then treating with chemotherapy and radiation. While this treatment plan is the currently accepted standard of care, it does not effectively prevent tumor recurrence, which ultimately causes death in GBM patients. This factor is expected to be the prime restraint for the growth of recurrent glioblastoma multiforme market.
Recurrent Glioblastoma Multiforme (GBM) market is segmented on the basis of treatment, end user and geography.
Primary treatment involves surgery to achieve tumor debulking, followed by a multimodal regimen of radiotherapy and chemotherapy. Chemotherapy can be added to radiotherapy for patients with unfavorable low-grade glioma to improve progression free survival. The most frequently used chemotherapy regimens are a combination of procarbazine, lomustine and vincristine, or single-agent treatment with carmustine or lomustine. Temozolomide is recommended by NICE as an option for the treatment of newly diagnosed GBM. Concomitant and adjuvant chemotherapy with temozolomide given during and after radiotherapy improves survival. This drug used along with chemotherapy or radiotherapy has led to the growth of GBM treatment market to a great extent.
Region wise, the global recurrent glioblastoma multiforme (GBM) market is classified into regions namely, North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America and Europe dominates the global GBM market owing to rising awareness, population aging, changing lifestyle and increasing healthcare awareness accentuates the growth of GBM market in these regions. In addition, Asia-Pacific region is expected to be an emerging market due to increasing demand for better healthcare facilities.
To View TOC of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/toc/10112
Some of the companies competing in recurrent glioblastoma multiforme (GBM) treatment market are Astrazeneca, F. Hoffman-La Roche, Ltd., GlaxoSmithKline plc., Merck & Co., Inc., Pfizer, Inc., AngioChem, Inc. Vascular Biogeneics and others.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Recurrent Glioblastoma Multiforme (GBM) Treatment Market is Growing at Significant Rate, 2022 here
News-ID: 550855 • Views: …
More Releases from Persistence Market Research
Off-Highway Radiators Market to Reach US$ 7.2 Bn by 2033 as Leading Players Like …
The off-highway radiators market plays a vital role in ensuring efficient thermal management in heavy-duty equipment used across construction, agriculture, mining, and forestry sectors. These radiators regulate engine temperatures, prevent overheating, and support consistent equipment performance under extreme operating conditions. Growing mechanization and the expansion of infrastructure projects worldwide are increasing reliance on durable cooling systems. Equipment manufacturers are prioritizing high-performance radiators that offer reliability, longer service life, and resistance…
ODM and EMS Wi-Fi Devices Market to Reach US$ 40.8 Billion by 2033 at 15.6% CAGR
The global ODM and EMS Wi-Fi devices market is projected to be valued at US$ 14.8 billion in 2026 and is forecast to surge to US$ 40.8 billion by 2033, registering a robust CAGR of 15.6% between 2026 and 2033. This rapid growth reflects the accelerating demand for advanced wireless connectivity solutions across residential, enterprise, and industrial environments. The expansion of 5G infrastructure, enterprise digital transformation strategies, and large-scale IoT…
Zink Printing Market to Reach US$ 2,126.0 Million by 2033 at 3.9% CAGR
Zink Printing Market Size and Trends Analysis
The global Zink printing market is projected to be valued at US$ 1,626.5 million in 2026 and is expected to reach US$ 2,126.0 million by 2033, expanding at a CAGR of 3.9% between 2026 and 2033. Zink (Zero Ink) printing technology eliminates the need for ink cartridges by using heat-activated color crystals embedded within specialized paper. This innovation has positioned Zink printers as a…
Indium Phosphide Market to Reach US$ 8.7 Billion by 2033 at 5.5% CAGR
The global Indium Phosphide (InP) market is poised for steady expansion, with its valuation expected to reach US$ 6.0 billion by 2026 and further grow to US$ 8.7 billion by 2033, registering a CAGR of 5.5% between 2026 and 2033. Indium phosphide, a high-performance compound semiconductor material, is widely used in optoelectronics, high-frequency electronics, and photonic integrated circuits (PICs). The market growth is largely fueled by the accelerating deployment of…
More Releases for GBM
Glioblastoma Multiforme (GBM) Treatment Market Report 2024: Trends and Projectio …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Glioblastoma Multiforme (GBM) Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $3.66 billion In…
Goodpasture Syndrome (Anti-GBM Disease) With Excellent CAGR 5.30%
Goodpasture Syndrome Treatment market analysis report is a professional and a detailed market study focusing on primary and secondary drivers, market share, leading segments, and geographical analysis. This market report is a comprehensive background analysis of the ABC industry, which includes an assessment of the parental market. The report also aids in prioritizing market goals and attain profitable business. This analysis gives an examination of various segments that are relied…
Anti-GBM Autoantibody Disease Market - Embracing Immune Harmony: Anti-GBM Autoan …
Newark, New Castle, USA - new report, titled Anti-GBM Autoantibody Disease Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Anti-GBM Autoantibody Disease market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Anti-GBM Autoantibody Disease market. The report offers an overview of…
Glioblastoma Multiforme Treatment (GBM) Market: Trends, Opportunities & Regional …
The global glioblastoma multiforme treatment market is anticipated to rise significantly owing to key players adopting competitive strategies such as merger and acquisitions for marketing. According to a report by Transparency Market Research, the key players in the global glioblastoma multiforme treatment are adopting strategies such as development of biological drugs that helps in reducing the side effects in the patients which are caused due to consuming chemotherapeutic agents and…
Understanding Impact of COVID-19 on Glioblastoma Multiforme (GBM) Market
Glioblastoma Multiforme (GBM), also known as glioblastoma, is a form of brain cancer. It is a rapidly-growing glioma that develops from star-shaped glial cells, such as oligodendrocytes and astrocytes that support the nerve cells in the brain. GBM is also called as grade IV astrocytoma and is among the most invasive forms of glial tumors. It is a fast-growing and aggressive form of tumor in the central nervous system (CNS)…
2019 - 2025 Glioblastoma Multiforme Treatment Market | GBM Market
Global Glioblastoma Multiforme Treatment Market, Its Market Trends And Analysis
Glioblastoma multiforme is the high-grade glioma and potent malignant brain tumor that affects glial cells. Glioblastoma multiforme contains the complexly differentiated neoplastic astrocytes which are the subtype of central nervous system. Glioblastoma multiforme is different from the anaplastic astrocytoma due to the presence of hyperplastic blood vessels and necrotic tissue.
Request Sample Report:
https://precisionbusinessinsights.com/request-sample?product_id=16248
The global glioblastoma multiforme treatment market is…
